{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T11:19:23Z","timestamp":1705490363745},"reference-count":39,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":479,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2000,9]]},"abstract":"<jats:p>In the myelodysplastic syndromes (MDS), P\u2010glycoprotein (P\u2010gp) expression is clinically associated with drug resistance, whereas the clinical significance of multidrug resistance\u2010associated protein (MRP1) is uncertain. Bone marrow from 56 patients with MDS, including six with refractory anaemia (RA)\/RA with ringed sideroblasts (RARS), 23 cases of RA with excess blasts\/in transformation (RAEB\/T), four patients with chronic myelomonocytic leukaemia (CMML) and 23 cases of MDS having progressed to acute myeloid leukaemia (MDS\u2010AML), were studied. MRP1 expression was investigated by immunocytochemistry (ICC) and by flow cytometry using MRPm6 monoclonal antibody. The efflux test using calcein\u2010AM (CAM)\u2003\u00b1\u2003probenecid to evaluate MRP1 activity was performed in ten of the 56 patients. Twenty\u2010eight of the 56 cases (50%) expressed MRP1. MRP1 expression was more frequent in MDS\u2010AML than in MDS (70% vs. 36%). The efflux test using CAM was positive in three out of the ten patients tested. The results were in agreement with expression of MRP1 in six cases, and were discordant in four cases (1 MRP\u2010\/CAM+, 3 MRP+\/CAM\u2013). No correlation was observed between MRP1 expression and P\u2010gp, lung resistance\u2010associated protein (LRP) or CD34 expression, although there was a trend for more frequent MRP1 expression in P\u2010gp\u2010positive cases in MDS\u2010AML (<jats:italic>P<\/jats:italic>\u2003=\u20030\u00b708). Ten of the 26 patients treated with intensive chemotherapy achieved complete remission including six out of 16 MRP1+ and four out of ten MRP1\u2013 cases (<jats:italic>P<\/jats:italic>\u2003=\u2003NS). In conclusion, MRP1 expression was correlated with disease stage in MDS in our study. As for P\u2010gp, discordant expression\/function of MRP1 could be found in some cases, suggesting the existence of non\u2010functional transport proteins in MDS. MRP1 expression did not seem to be a prognostic factor in MDS in our experience<jats:bold>.<\/jats:bold><\/jats:p>","DOI":"10.1046\/j.1365-2141.2000.02247.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:27:22Z","timestamp":1047364042000},"page":"591-598","update-policy":"http:\/\/dx.doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Expression of the multidrug resistance\u2010associated protein in myelodysplastic syndromes"],"prefix":"10.1111","volume":"110","author":[{"given":"St\u00e9phanie","family":"Poulain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascale","family":"Lepelley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claude","family":"Preudhomme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathalie","family":"Cambier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e9rome","family":"Cornillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Wattel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Cosson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Fenaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_6_2_1","first-page":"799","article-title":"Lack of correlation between expression and function of P\u2010glycoprotein in acute myeloid leukemia cell lines","volume":"9","author":"Bailly D.","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_6_3_1","first-page":"3010","article-title":"Methods to detect P\u2010glycoprotein\u2010associated multidrug resistance in patients tumors: consensus recommendations","volume":"56","author":"Beck W.T.","year":"1996","journal-title":"Cancer Research"},{"key":"e_1_2_6_4_1","first-page":"990","article-title":"Expression of the multidrug resistance associated protein (MRP) in acute and chronic leukemias","volume":"8","author":"Burger H.","year":"1994","journal-title":"Leukemia"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4613-1267-3_2"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1360704"},{"key":"e_1_2_6_7_1","first-page":"5902","article-title":"Pharmacological characterisation of multidrug resistant MRP\u2010transfected human tumor cells","volume":"54","author":"Cole S.P.C.","year":"1994","journal-title":"Cancer Research"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1995.328"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1021\/bi9718043"},{"key":"e_1_2_6_10_1","first-page":"1419","article-title":"MRP expression in acute myeloid leukemia has no impact on treatment outcome","volume":"8","author":"Filipits M.","year":"1997","journal-title":"Clinical Cancer Research"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-4811-9_16"},{"key":"e_1_2_6_12_1","first-page":"1237","article-title":"Tissue distribution of the Multidrug Resistance Protein","volume":"148","author":"Flens M.","year":"1996","journal-title":"American Journal of Pathology"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002800050640"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.62.070193.002125"},{"key":"e_1_2_6_15_1","first-page":"2163","article-title":"Expression of the multidrug resistance\u2010associated protein (MRP) in acute leukemia","volume":"8","author":"Hart S.M.","year":"1994","journal-title":"Leukemia"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1998.642"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/(sici)1097-0215(19960117)65:2<230::aid-ijc17>3.0.co;2-h"},{"key":"e_1_2_6_18_1","first-page":"3537","article-title":"Analysis of expression of cMOAT (MRP2), MRP3, MRP4 and MRP5, homologues of the multidrug resistance\u2010associated protein gene (MRP1), in human cancer cell lines","volume":"57","author":"Kool M.","year":"1997","journal-title":"Cancer Research"},{"key":"e_1_2_6_19_1","first-page":"1549","article-title":"Multi\u2010drug resistance (MDR) activity in acute leukemia determined by rhodamine 123 efflux assay","volume":"9","author":"Lamy T.","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1996.d01-1776.x"},{"key":"e_1_2_6_21_1","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.1182\/blood.V91.12.4480","article-title":"P\u2010gp and MRP activities using calcein\u2010AM are prognostic factors in adult acute myeloid leukemia patients","volume":"91","author":"Legrand O.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V94.3.1046.415k03_1046_1056"},{"key":"e_1_2_6_23_1","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1182\/blood.V86.6.2329.bloodjournal8662329","article-title":"Correlation of multidrug resistance (MDR1) protein expression with functional dye\/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: identification of discordant MDR1\u2010\/efflux+ and MDRl+\/efflux\u2010cases","volume":"86","author":"Leith C.P.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_6_24_1","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1182\/blood.V89.9.3323","article-title":"Acute myeloid leukemia in the ederly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biological subgroups with remarkebly distinct responses to standard chemotherapy. A Southwest Oncology Group study","volume":"89","author":"Leith C.P.","year":"1997","journal-title":"Blood"},{"key":"e_1_2_6_25_1","first-page":"1086","article-title":"Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1\/P\u2010glycoprotein, MRP1, and LRP in acute myeloid leukemia. A Southwest Oncology Group study","volume":"94","author":"Leith C.P.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_6_26_1","first-page":"998","article-title":"Expression of multidrug resistance P\u2010Glycoprotein and its relationship to hematological characteristics and response to treatment in myelodysplastic syndromes","volume":"8","author":"Lepelley P.","year":"1994","journal-title":"Leukemia"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428199809050914"},{"key":"e_1_2_6_28_1","first-page":"879","article-title":"Multidrug resistance (MDR1) gene expression in adult acute leukemias: correlation with treatment outcome and in vitro drug sensitivity","volume":"6","author":"Marie J.P.","year":"1991","journal-title":"Blood"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400656"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.d01-2020.x"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-4811-9_7"},{"key":"e_1_2_6_32_1","first-page":"48","article-title":"Expression of multidrug resistance\u2010associated protein (MRP) mRNA in blast cells from acute myeloid leukemia patients","volume":"10","author":"Ross D.D.","year":"1996","journal-title":"Leukemia"},{"key":"e_1_2_6_33_1","first-page":"1475","article-title":"Overexpression of a M1 110.000 vesicular protein in non P\u2010Glycoprotein mediated multidrug","volume":"53","author":"Scheper R.J.","year":"1993","journal-title":"Cancer Research"},{"key":"e_1_2_6_34_1","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1182\/blood.V85.1.186.bloodjournal851186","article-title":"Increased expression of the multidrug resistance associated protein gene in relapsed acute leukemia","volume":"85","author":"Schneider E.","year":"1995","journal-title":"Blood"},{"key":"e_1_2_6_35_1","first-page":"1727","article-title":"Activity and expression of the multidrug resistance proteins MRP1 and MRP2 in acute myeloid leukemia cells, tumor cell lines, and normal hematopoietic CD34+ peripheral cells","volume":"4","author":"Van der Kolk D.M.","year":"1998","journal-title":"Clinical Cancer Research"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910630617"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1998.00870.x"},{"key":"e_1_2_6_38_1","first-page":"1882","article-title":"Discordant P\u2010glycoprotein antigen and transport function in acute myeloid leukemia","volume":"9","author":"Xie X.Y.","year":"1995","journal-title":"Leukemia"},{"key":"e_1_2_6_39_1","first-page":"871","article-title":"Glutathione\u2010related mechanisms in cellular resistance to anticancer drugs","volume":"12","author":"Zhang K.","year":"1998","journal-title":"International Journal of Oncology"},{"key":"e_1_2_6_40_1","first-page":"1661","article-title":"Expression of multidrug resistance\u2010associated protein (MRP) and multidrug resistance (MDR1) genes in acute leukemia","volume":"9","author":"Zhou D.C.","year":"1995","journal-title":"Leukemia"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.02247.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2000.02247.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2000.02247.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T09:11:38Z","timestamp":1698570698000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2000.02247.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2000,9]]}},"alternative-id":["10.1046\/j.1365-2141.2000.02247.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2000.02247.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,9]]},"assertion":[{"value":"2001-12-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}